CD68 and malaria: Our data indicate that blockage of galectin-receptor interactions may increase the activity of liver CD68+ macrophages in the erythrocytic stage of malaria, which is in agreement with the increased parasitemia and tissue parasite burden in malarial mice with α-lactose treatment.